HLA-DOA and cervical carcinoma: T178G (D25E) variations are mainly distributed in the Asian population (such as China, Japan and South Korea) [21, 22]; the mutation can interact with Human Lymphocyte Antigen (HLA) gene polymorphisms and promote the development of cervical cancer.